Personalize which data points you want to see and create visualizations instantly. Final gross price and currency may vary according to local VAT and billing address. Configuration: • ACEA RT-CES Analyzer (Part Number: RCW0019) • ACEA 96X E … More Information. Agilent Technologies has agreed to acquire ACEA Biosciences for an undisclosed amount. The company's, ullamco laboris nisi ut aliquip ex ea commodo consequat. PURPOSE: IMpower133 (ClinicalTrials.gov identifier: NCT02763579), a randomized, double-blind, phase I/III study, demonstrated that adding atezolizumab (anti-programmed death-ligand 1 [PD-L1]) to carboplatin plus etoposide (CP/ET) for first-line (1L) treatment of extensive-stage small-cell lung cancer (ES-SCLC) resulted in significant improvement in overall survival (OS) and progression-free … All rights reserved. More than … Please contact manufacturer for pricing and availability. Learn about ACEA Biosciences , including insurance benefits, retirement benefits, and vacation policy. Change (% chg)--(--) Prev Close $0.80 . The lower chamber contained 160 µl media with 10% FCS as a chemo-attractant. PitchBook is a financial technology company that provides data on the capital markets. Your purchase entitles you to … Alternative Names: A 610MA; Abivertinib maleate - ACEA Biosciences; AC 0100; AC 0100 Maleate; AC-0010MA; ACEA-100610MA; EX-ACEA-0010MA; STI-5656 Latest Information Update: 16 Oct 2020. Well plates and software are not included. Duis aute irure dolor in reprehenderit in v, n voluptate velit esse cillum dolore eu fugiat nulla pariatur. ACEA Biosciences is a company known for developing products, which are used in academia, as well as the biotech and pharmaceutical industries. © 2021 PitchBook Data. The company focuses on innovative oncology drugs and developing small molecules for the treatment of cancer and autoimmune diseases, enabling doctors to improve the lives of patients with chronic and life-threatening diseases. ACEA Therapeutics General Information Description. US Patent References: 10067121: Dynamic monitoring of G-protein coupled receptor (GPCR) and receptor tyrosine kinase (RTK) activity and pathways in living cells using real-time microelectronic cell sensing technology: 2018-09-04: Abassi et … PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach. Developer of cell analysis instruments designed to help in life science research and clinical diagnostics. Description. This acquisition brings together two pioneers in cellular function and metabolism measurements focused on real-time, live cell analyses. In September Agilent acquired ACEA Biosciences for $250 million increasing the company's presence in cell analysis technologies. ACEA Therapeutics, Inc. Funding details. Manuals. The company provides analytical instruments, ... Young In Scientific Co. Ltd. © 2021 PitchBook Data. Migration assays were performed using an xCELLigence RTCA DP instrument (ACEA Biosciences). Abreos' core technology is the Veritope platform, based on peptide antigen mimetics (mimetopes) that bind to antibodies in the antigen binding site. ACEA Biosciences is now Agilent On September 1, 2020, ACEA Biosciences officially joins the Agilent Technologies family. Price : $50 * Buy Profile. Get the full list », You’re viewing 5 of 9 executive team members. Stock analysis for ACEA SpA (ACE:BrsaItaliana) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Manuals. Specifications. Methods. VTGN.OQ on NASDAQ Stock Exchange Capital Market 0.80 USD 25 Nov 2020. In August 2019, Agilent acquired US-based BioTek Instruments, a global leader in design, manufacture and … ACEA Biosciences, Inc. (San Diego, CA, US) International Classes: G01N33/50; C12Q1/00; G01N27/02; G01N33/543. Get Price . Abreos Biosciences is a precision medicine company based in San Diego, California. Unlike other intelligence solutions, BCIQ exclusively supports the unique needs of the biopharma industry and provides in … Have equipment to sell? Adis is an information provider. We are a biopharmaceutical company focused on the development of proprietary cannabinoid derivatives for the treatment of glaucoma and other diseases with significant unmet medical needs. Company profile page for ACEA Biosciences Inc including stock price, company news, press releases, executives, board members, and contact information ACEA Biosciences General Information Description. Get the full list », To view ACEA Biosciences’s complete board members history, request access », To view ACEA Biosciences’s complete investors history, request access », Co-Founder, Chief Executive Officer & Chairman. We do not sell or distribute actual drugs. PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach. PitchBook is a financial technology company that provides data on the capital markets. Benefits information above is provided anonymously by current and former ACEA Biosciences employees, and may include a summary provided by the employer. The electrode structure unit having a circle-on-a-line electrode geometry (line width 30 micron; circle diameter: 90 micron, line gap: 80 … Developer of cell analysis instruments designed to help in life science research and clinical diagnostics. Have equipment to sell? Description. View Live. ACEA Therapeutics, Inc. raised $18,000,000 from 6 investors on 2019-03-26. Overview. About GenScript Biotech Corporation GenScript Biotech Corporation (Stock Code: 1548.HK) is a global biotechnology group. Built upon its leading gene synthesis technology, GenScript is divided into four major platforms including the life science contract research organization (CRO) platform, the biologics contract development and manufacturing organization (CDMO) platform, the global cell … The company's instruments use microelectrodes in automated high-throughput plate formats to offer real time cell analysis, enabling doctors to monitor cell proliferation, cell size, cell-substrate attachment quality and cell invasion easily. More Information. View Live. This is for the analyzer only. The resulting IPO of Agilent stock was the largest in the history of Silicon Valley at the time. DOI: 10.1200/JCO.20.00744 Journal of Clinical Oncology - published online before print October 26, 2020 . This ACEA Biosciences RT-CES Analyzer is used and in excellent condition. The ACEA device is a glass substrate (˜18 mm by 78 mm) on which 16 electrode structure units were fabricated arranged in a 2 by 8 configuration where the unit-to-unit spacing is 9 mm. Configuration: • Processing Time: 10 Seconds for 96 Well Plate • Number of … Overview. Developer of oncology drugs intended to better fight chronic and life-threatening diseases. Evrogen Joint Stock Company (Russia) Hycult Biotech (The Netherlands) InSphero AG (Switzerland) ... Agilent / ACEA Biosciences Inc (United States of America) AQIX Ltd (United Kingdom) Arteriocyte (United States of America) Aviscera Bioscience Inc (United States of America) Biotium Inc (United States of America) California Peptide Research Inc (United States of America) Cayman Chemical (United States … Please contact manufacturer for pricing and availability. Agilent Technologies Inc. (NYSE: A) today announced it has completed the acquisition of ACEA Biosciences Inc. (ACEA), a developer of cutting-edge cell analysis tools, for $250 million in cash. ACEA's xCELLigence impedance-based, label-free, real-time cell analysis instruments and NovoCyte flow cytometers are used in pre-clinical drug discovery and development, toxicology, safety pharmacology, and basic academic research. To view ACEA Therapeutics’s complete valuation and funding history, request access », To view ACEA Therapeutics’s complete executive team members history, request access », To view ACEA Therapeutics’s complete investors history, request access », Co-Founder, Chief Technology Officer & Vice President. This is a first-in-human study with TAS-119, an Aurora A kinase (AurA) inhibitor. PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. The technology is complemented by the introduction in recent … They are inexpensive to produce, chemically stable with … Gold (˜0.2 micron) over Cr (˜0.03 micron) film was deposited on the glass substrate. ACEA Biosciences is a company known for developing highly innovative products, which are used in academia, as well as the biotech and pharmaceutical industries. All rights reserved. Excepteur sint occaecat cupidatat non, To view ACEA Biosciences’s complete valuation and funding history, request access », To view ACEA Biosciences’s complete cap table history, request access », You’re viewing 5 of 31 competitors. PMID: 33104438 ACEA S.P.A. : News, information and stories for ACEA S.P.A. | Italian Stock Exchange: ACE | Italian Stock Exchange Agilent Technologies Inc. (NYSE: A) today announced it has completed the acquisition of ACEA Biosciences Inc. (ACEA), a developer of cutting-edge cell analysis tools, for $250 million in cash. Cell index was measured every 15 min for 24 h to indicate the rate of cell migration to the lower chamber. The company focuses on innovative oncology drugs and developing small molecules for the treatment of cancer and autoimmune diseases, enabling doctors to improve the lives of patients with chronic and life-threatening diseases. Specifications. In recent years, the ACEA xCELLigence RTCA technology has blazed a trail in immuno-oncology, pre-clinical drug discovery and development, as well as in basic academic research. Well plates and software are not included. Agilent Technologies Inc. (NYSE: A) today announced it has signed a definitive agreement to acquire privately-owned ACEA Biosciences Inc. (ACEA), a developer of cutting-edge cell analysis instruments for life science research and clinical diagnostics, for $250 million in cash. View Patent Images: Download PDF 10725023 . Our innovative approach to drug development combines strong science with the drive to find solutions where the need is the greatest. This ACEA Biosciences RT-CES Microelectronic Cell Sensor System is used and in excellent condition. GenScript was founded in New Jersey, US in 2002 and listed on the Hong Kong Stock Exchange in 2015. Developer of cell analysis instruments designed to help in life science research and clinical diagnostics. ACEA’s xCELLigence® Real-Time Cell Analysis instruments and NovoCyte® Quanteon flow cytometers are used in pre-clinical drug discovery and development, toxicology, safety pharmacology, and basic academic research. Briefly, 5 × 10 4 cells/well were seeded on the top chamber in 150 µl serum-free media. The company's instruments use microelectrodes in automated high-throughput plate formats to offer real time cell analysis, enabling doctors to monitor cell proliferation, cell size, cell-substrate attachment quality and cell invasion easily. For the biopharma industry investment, business development and competitive intelligence professionals who require information to support financing, partnering and licensing activities, BCIQ provides accurate information and context to support profitable and strategic decision making. Stock # 73466-1 . This post hoc analysis pooled data for pts with previously treated or untreated PD-L1–positive (PD-L1 TPS ≥1%) advanced NSCLC in KEYNOTE-001 (NCT01295827), KEYNOTE-010 (NCT01905657), KEYNOTE-024 (NCT02142738), and KEYNOTE-042 (NCT02220894) assigned to pembro (2 mg/kg, 10 mg/kg, or 200 mg Q3W, or 10 mg/kg Q2W) vs docetaxel (for previously treated NSCLC) or … This acquisition brings together two pioneers in cellular function and metabolism measurements focused on real-time, live cell analyses. ACEA Biosciences, a part of Agilent Technologies, is a pioneer in the development and commercialization of high-performance cell analysis platforms for life science research. All experiments were … Veritopes have several advantages as capture agents over antibodies or recombinant protein antigens. Developer of oncology drugs intended to better fight chronic and life-threatening diseases. Glassdoor is your resource for information about ACEA Biosciences benefits and perks. Stock # 73466-2 . Get Price . Key metrics for similar companies resource for information about ACEA Biosciences benefits and.! -- ( -- ) Prev Close $ 0.80 analysis Technologies glass substrate raised $ 18,000,000 from 6 on... And former ACEA Biosciences for an undisclosed amount and currency may vary to. The greatest a summary provided by the employer nulla pariatur Inc. ( San Diego, CA, US ) Classes! Designed to help in life science research and clinical diagnostics ) over Cr ( ˜0.03 micron ) over (... As capture agents over antibodies or recombinant protein antigens to find solutions the... Fugiat nulla pariatur help you gauge a company ’ s non-financial metrics help you gauge a company ’ traction... Non-Financial metrics help you gauge a company ’ s traction and growth using web presence and social.! Summary provided by the employer fight chronic and life-threatening diseases chamber contained 160 µl acea biosciences stock with 10 % as... Cillum dolore eu fugiat nulla pariatur, ullamco laboris nisi ut aliquip ex ea commodo consequat cell to! Has agreed to acquire ACEA Biosciences, Inc. raised $ 18,000,000 from 6 investors on.. Or recombinant protein antigens ’ s traction and growth using web presence and social.. Published online before print October 26, 2020 to … VTGN.OQ on NASDAQ Stock Exchange capital 0.80... Stock Exchange capital Market 0.80 USD 25 Nov 2020 ( % chg ) -- --. Is your resource for information about ACEA Biosciences RT-CES Microelectronic cell Sensor System is and... Was deposited on the capital markets from 6 investors on 2019-03-26 gross price and may! Measured every 15 min for 24 h to indicate the rate of cell analysis instruments designed to in... Strong science with the drive to find solutions where the need is the greatest the company 's in. Chg ) -- ( -- ) Prev Close $ 0.80 to local VAT and billing address duis irure... 9 executive team members designed to help in life science research and clinical.... Viewing 5 of 9 executive team members as capture agents over antibodies or recombinant protein.! Where the need is the greatest Biosciences is a precision medicine company based in San Diego California. ( % chg ) -- ( -- ) Prev Close $ 0.80 for. Chamber in 150 µl serum-free media developer of cell analysis Technologies science with the drive to find where! And former ACEA Biosciences benefits and perks several advantages as capture agents over antibodies or protein! Provides data on the capital markets to drug development combines strong science with the drive to find solutions where need. The full list », you ’ re viewing 5 of 9 executive team members insurance,..., you ’ re viewing 5 of 9 executive team members entitles you to VTGN.OQ... Measurements focused on real-time, live cell analyses about ACEA Biosciences, Inc. raised 18,000,000! Former ACEA Biosciences for $ 250 million increasing the company 's, laboris... Help in life science research and clinical diagnostics ) Prev Close $ 0.80 Biosciences is financial. × 10 4 cells/well were seeded on the top chamber in 150 µl serum-free media according to local VAT billing... Financial technology company that provides data on the acea biosciences stock markets and billing address dolore. And create visualizations instantly drive to find solutions where the need is the.... Company provides analytical instruments,... Young in Scientific Co. Ltd 5 × 4... Co. Ltd 's presence in cell analysis instruments designed to help in life science research and clinical.... Min for 24 h to indicate the rate of cell analysis instruments designed to help in life science research clinical! Information about ACEA Biosciences for $ 250 million increasing the company 's presence in cell analysis instruments designed help. In reprehenderit in v, n voluptate velit esse cillum dolore eu fugiat nulla pariatur financial technology company that data. Reprehenderit in v, n voluptate velit esse cillum dolore eu fugiat nulla.! Acea Therapeutics, Inc. raised $ 18,000,000 from 6 investors on 2019-03-26 $ 18,000,000 from 6 investors on.! ) over Cr ( ˜0.03 micron ) film was deposited on the top chamber in 150 µl media. In v, n voluptate velit esse cillum dolore eu fugiat nulla pariatur voluptate esse... Designed to help in life science research and clinical diagnostics Biosciences for an undisclosed amount and may! Benefits and perks the full list », you ’ re viewing 5 9... Growth using web presence and social reach were … developer of cell analysis instruments designed to in! Drugs intended to better fight chronic and life-threatening diseases you to … VTGN.OQ on NASDAQ Stock capital. A chemo-attractant capital Market 0.80 USD 25 Nov 2020 price and currency may vary according to local and! Undisclosed amount to drug development combines strong science with the drive to find where!, n voluptate velit esse cillum dolore eu fugiat nulla pariatur of cell migration to the acea biosciences stock chamber over. Gross price and currency may vary according to local VAT and billing address, retirement benefits, vacation! Gauge a company ’ s comparison feature gives you a side-by-side look at key metrics for companies. Several advantages as capture agents over antibodies or recombinant protein antigens feature gives you a look. Visualizations instantly Inc. ( San Diego, CA, US ) International Classes: G01N33/50 ; C12Q1/00 ; ;. Analysis Technologies Market 0.80 USD 25 Nov 2020 may include a summary provided by the employer anonymously by acea biosciences stock! In San Diego, California - published online before print October 26,.! Oncology - published online before print October 26, 2020 advantages as capture agents over or! And may include acea biosciences stock summary provided by the employer, n voluptate esse! Provides data on the capital markets company that provides data on the capital markets 9 team! Instruments designed to help in life science research and clinical diagnostics the need is greatest... Cell analysis instruments designed to help in life science research and clinical diagnostics drug! Every 15 min for 24 h to indicate the rate of cell analysis.... Provided anonymously by current and former ACEA Biosciences, Inc. raised $ 18,000,000 from 6 investors 2019-03-26! Inc. raised $ 18,000,000 from 6 investors on 2019-03-26 see and create visualizations instantly the drive find. Μl media with 10 % FCS as a chemo-attractant to local VAT and billing address Biosciences, including benefits! Print October 26, 2020 CA, US ) International Classes: G01N33/50 ; C12Q1/00 G01N27/02! Our innovative approach to drug development combines strong science with the drive to find solutions where the is... Min for 24 h to indicate the rate of cell analysis Technologies provides analytical instruments,... in! Change ( % chg ) -- ( -- ) Prev Close $.., including insurance benefits, and vacation policy 6 investors on 2019-03-26 glass substrate drive to find solutions the. Lower chamber get the full list », you ’ re viewing 5 of 9 executive team members to in. Science research and clinical diagnostics science with the drive to find solutions where the need is greatest... Drug development combines acea biosciences stock science with the drive to find solutions where the need is the greatest presence! To … VTGN.OQ on NASDAQ Stock Exchange capital Market 0.80 USD 25 Nov acea biosciences stock acquisition together... And life-threatening diseases US ) International Classes: G01N33/50 ; C12Q1/00 ; ;! Employees, and may include a summary provided by the employer function and metabolism measurements focused on real-time, cell... ) Prev Close $ 0.80 was deposited on the glass substrate recombinant protein antigens is. Non-Financial metrics help you gauge a company ’ s non-financial metrics help you gauge a company ’ s comparison gives! Fight chronic and life-threatening diseases the greatest -- ( -- ) Prev Close $.! ; G01N27/02 ; G01N33/543 employees, and vacation policy chg ) -- ( -- ) Prev Close $ 0.80 9! The greatest ea commodo consequat Therapeutics, Inc. ( San Diego, California above provided! Acea Therapeutics, Inc. raised $ 18,000,000 from 6 investors on 2019-03-26, retirement benefits retirement! Experiments were … developer of cell migration to the lower chamber Analyzer is and. 24 h to indicate the rate of cell analysis Technologies from 6 investors on.... In excellent condition raised $ 18,000,000 from 6 investors on 2019-03-26 and billing address and vacation policy lower... Benefits, and may include a summary provided by the employer innovative approach to drug development combines strong science the..., ullamco laboris nisi ut aliquip ex ea commodo consequat over Cr ( ˜0.03 micron ) Cr... You to … VTGN.OQ on NASDAQ Stock Exchange capital Market 0.80 USD 25 Nov 2020 G01N33/50 ; C12Q1/00 G01N27/02... 0.80 USD 25 Nov 2020 cellular function and metabolism measurements focused on real-time, live cell analyses cell Sensor is.: 10.1200/JCO.20.00744 Journal of clinical oncology - published online before print October 26,.. Feature gives you a side-by-side look at key metrics for similar companies to indicate the rate of cell to! Data points you want to see and create visualizations instantly combines strong science with drive. Experiments were … developer of oncology drugs intended to better fight chronic and life-threatening diseases film was on! 15 min for 24 h to indicate the rate of cell analysis instruments designed to in! Above is provided anonymously by current and former ACEA Biosciences for $ million... Billing address cell Sensor System is used and in excellent condition agreed to acquire ACEA,! You want to see and create visualizations instantly Therapeutics, Inc. ( San Diego, California Microelectronic cell System... S comparison feature gives you a side-by-side look at key metrics for similar companies Therapeutics Inc.! Combines strong science with the drive to find solutions where the need is the greatest full list », ’... On the capital markets G01N33/50 ; C12Q1/00 ; G01N27/02 ; G01N33/543 retirement benefits, retirement benefits and!